GO
Loading...

Enter multiple symbols separated by commas

Drugs

More

  • Will ghoulish investments pay off? Monday, 16 Jun 2014 | 6:57 PM ET
    Elderly women wait for lunch to be served at a day care facility on Gogo Island in Matsuyama, Ehime Prefecture, Japan

    As the global population ages, some see investment opportunities in somewhat ghoulish bets the rates of cancer and other illnesses will rise.

  • Mexico's most feared drug cartel   Thursday, 12 Jun 2014 | 1:32 PM ET

    CNBC's Andrea Day looks into the FBI's investigation of the Los Zetas drug cartel, which used horse racing to launder money.

  • Orexigen shares plunge on FDA diet-drug delay Wednesday, 11 Jun 2014 | 7:33 AM ET

    Orexigen Therapeutics said the FDA delayed a decision on its obesity drug by three months, sending the company's shares down about 19 percent.

  • Merck proud to be a US-based company: CEO Wednesday, 4 Jun 2014 | 8:52 AM ET
    Ken Frazier, president and CEO of Merck.

    But Merck chief Kenneth Frazier also said the government needs to modify its high corporate tax code to level the playing field for American companies.

  • Chicago sues drugmakers, alleging painkiller risk Tuesday, 3 Jun 2014 | 10:37 AM ET

    Chicago filed a lawsuit against five pharmaceutical companies, accusing them of concealing the risks associated with certain painkillers.

  • Hate shots? New allergy options are on the way Monday, 2 Jun 2014 | 7:03 AM ET

    Patients can try new once-a-day tablets that dissolve quickly under the tongue and raise tolerance to grass or ragweed pollen, much like the shots.

  • What new GSK cancer deal shows about pharma market Monday, 2 Jun 2014 | 3:33 AM ET

    The announcement that GSK is planning to spend $350 million plus to get a slice of a U.K. biotech's cancer drugs has raised eyebrows.

  • Immunotherapies hit ASCO   Thursday, 29 May 2014 | 3:35 PM ET
    Immunotherapies hit ASCO

    This year's biggest cancer conference begins tomorrow. CNBC's Meg Tirrell reports why immunotherapy drugs will be a key theme with drug makers at ASCO.

  • GSK invites private equity bid for drugs: Sources Thursday, 29 May 2014 | 12:34 PM ET
    A GlaxoSmithKline Plc logo sits on a sign outside the company's headquarters in London, U.K.

    GSK has invited private equity firms to consider making offers for a range of its older drugs, three people with direct knowledge of the matter said.

  • Ataluren drives PTC Therapeutics   Friday, 23 May 2014 | 10:25 AM ET
    Ataluren drives PTC Therapeutics

    CNBC's Meg Tirrell reports shares of PTC Therapeutics are surging on a recommendation of the drug "Ataluren" designed to treat Duchenne muscular dystrophy which could be a billion dollar drug.

  • Pfizer: A deal to dodge the tax man in America Tuesday, 13 May 2014 | 2:28 AM ET

    Pfizer's pursuit of AstraZeneca raises a huge public policy red flag, writes Andrew Ross Sorkin in the New York Times.

  • Resolving drug issue will boost Colombia: Fin Min

    Colombian Finance Minister Mauricio Cárdenas Santamaria says resolving the country's drugs issue will help the country post stronger growth.

  • Biogen barreling down on Alzheimer's   Wednesday, 23 Apr 2014 | 3:33 PM ET
    Biogen barreling down on Alzheimer's

    CNBC's Meg Tirrell speaks with George Scangos, Biogen Idec CEO, about the drug maker's fight against MS and Alzheimer's. Scangos also comments on Valeant's bid for Alllergan.

  • Investor pressure pushing drugmaker M&A deals Wednesday, 23 Apr 2014 | 6:11 AM ET
    Valeant Pharmaceuticals sign at the company's headquarters in Mississauga, Ontario.

    Drugmakers eager to satisfy shareholders are wheeling, dealing, and in one case even making trades like a pro sports team looking to shake up its roster.

  • On a high: Hemp to boost US economy?   Wednesday, 16 Apr 2014 | 11:40 AM ET
    On a high: Hemp to boost US economy?

    The hemp industry could become one of the U.S.'s biggest now its industrial use had been legalized, says Doug Fine, author of "Hemp Bound".

  • Mexico, US need to 'collaborate' on drug cartels: Fin Min

    Luis Videgaray, finance minister of Mexico, says the U.S. must "share responsibility" for tackling drug cartels.

  • Pfizer CEO worries about ACA coverage   Thursday, 10 Apr 2014 | 11:43 AM ET
    Pfizer CEO worries about ACA coverage

    Ian Read, Pfizer CEO, discusses the pricing and affordability of drugs in the U.S. Read also weighs in on insurance coverage under the Affordable Care Act.

  • Diversifying your pharma portfolio   Monday, 7 Apr 2014 | 1:07 PM ET
    Diversifying your pharma portfolio

    Mallinckrodt is buying drug maker Questcor for $5.6 billion. Barbara Ryan, FTI Consulting managing director, discusses consolidation in pharmaceuticals and shares what stocks she likes in the space.

  • Why this $84,000 drug costs just $900 abroad Saturday, 29 Mar 2014 | 2:29 PM ET

    Why do some drugs, like Gilead's Sovaldi, cost more in the U.S. than in other countries. Shelia Dharmarajian reports for "Nightly Business Report."

  • 'Eye-opening' new report about statin eligibility Wednesday, 19 Mar 2014 | 5:06 PM ET
    Lipitor tablets

    Almost half of Americans ages 40 to 75 qualify to consider cholesterol-lowering statin drugs under new heart disease prevention guidelines.